304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma

304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma

Bibliographic Details
Main Authors: Kim Margolin, Antoni Ribas, Riyue Bao, Adil Daud, Mohammed Milhem, Elizabeth Buchbinder, Geoffrey Gibney, Jason Luke, Takami Sato, David Mauro, Yousef Zakharia, Theresa Medina, John Kirkwood, Jiaxin Niu, Katie Campbell, George Weiner, Inderjit Mehmi, Heather Kelley, James Wooldridge
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items